These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36755974)

  • 1. Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation.
    Perrone C; Pomella S; Cassandri M; Pezzella M; Giuliani S; Gasperi T; Porrazzo A; Alisi A; Pastore A; Codenotti S; Fanzani A; Barillari G; Conti LA; De Angelis B; Quintarelli C; Mariottini P; Locatelli F; Marampon F; Rota R; Cervelli M
    Front Cell Dev Biol; 2023; 11():1061570. PubMed ID: 36755974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells.
    Cassandri M; Pomella S; Rossetti A; Petragnano F; Milazzo L; Vulcano F; Camero S; Codenotti S; Cicchetti F; Maggio R; Festuccia C; Gravina GL; Fanzani A; Megiorni F; Catanoso M; Marchese C; Tombolini V; Locatelli F; Rota R; Marampon F
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression.
    Perrone C; Pomella S; Cassandri M; Pezzella M; Milano GM; Colletti M; Cossetti C; Pericoli G; Di Giannatale A; de Billy E; Vinci M; Petrini S; Marampon F; Quintarelli C; Taulli R; Roma J; Gallego S; Camero S; Mariottini P; Cervelli M; Maestro R; Miele L; De Angelis B; Locatelli F; Rota R
    Front Oncol; 2022; 12():835642. PubMed ID: 35574376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells.
    Ouchi K; Miyachi M; Yagyu S; Kikuchi K; Kuwahara Y; Tsuchiya K; Iehara T; Hosoi H
    Cancer Cell Int; 2020; 20():192. PubMed ID: 32489328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma.
    Hanna JA; Garcia MR; Go JC; Finkelstein D; Kodali K; Pagala V; Wang X; Peng J; Hatley ME
    Cell Death Dis; 2016 Jun; 7(6):e2256. PubMed ID: 27277678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma.
    Hanna JA; Garcia MR; Lardennois A; Leavey PJ; Maglic D; Fagnan A; Go JC; Roach J; Wang YD; Finkelstein D; Hatley ME
    Oncogene; 2018 Apr; 37(15):1991-2007. PubMed ID: 29367756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of DNA methylation to mutational changes and transcriptional organization in fusion-positive and fusion-negative rhabdomyosarcoma.
    Sun W; Chatterjee B; Shern JF; Patidar R; Song Y; Wang Y; Walker RL; Pawel BR; Linardic CM; Houghton P; Hewitt SM; Edelman DC; Khan J; Meltzer PS; Barr FG
    Int J Cancer; 2019 Jun; 144(11):2707-2717. PubMed ID: 30565669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Polyamine Catabolism Reduces Cellular Senescence.
    Uemura T; Matsunaga M; Yokota Y; Takao K; Furuchi T
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57
    Pomella S; Cassandri M; D'Archivio L; Porrazzo A; Cossetti C; Phelps D; Perrone C; Pezzella M; Cardinale A; Wachtel M; Aloisi S; Milewski D; Colletti M; Sreenivas P; Walters ZS; Barillari G; Di Giannatale A; Milano GM; De Stefanis C; Alaggio R; Rodriguez-Rodriguez S; Carlesso N; Vakoc CR; Velardi E; Schafer BW; Guccione E; Gatz SA; Wasti A; Yohe M; Ignatius M; Quintarelli C; Shipley J; Miele L; Khan J; Houghton PJ; Marampon F; Gryder BE; De Angelis B; Locatelli F; Rota R
    Nat Commun; 2023 Dec; 14(1):8373. PubMed ID: 38102140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Novel Substrate-Derived Spermine Oxidase Inhibitor.
    Dunston TT; Khomutov MA; Gabelli SB; Stewart TM; Foley JR; Kochetkov SN; Khomutov AR; Casero RA
    Acta Naturae; 2020; 12(3):140-144. PubMed ID: 33173604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KDM3A/Ets1 epigenetic axis contributes to PAX3/FOXO1-driven and independent disease-promoting gene expression in fusion-positive Rhabdomyosarcoma.
    Sobral LM; Hicks HM; Parrish JK; McCann TS; Hsieh J; Goodspeed A; Costello JC; Black JC; Jedlicka P
    Mol Oncol; 2020 Oct; 14(10):2471-2486. PubMed ID: 32697014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma.
    Milewski D; Shukla S; Gryder BE; Pradhan A; Donovan J; Sudha P; Vallabh S; Pyros A; Xu Y; Barski A; Szabo S; Turpin B; Pressey JG; Millay DP; Khan J; Kalinichenko VV; Kalin TV
    Oncogene; 2021 Mar; 40(12):2182-2199. PubMed ID: 33627785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAK Signaling in Rhabdomyosarcoma.
    Perrone C; Pomella S; Cassandri M; Braghini MR; Pezzella M; Locatelli F; Rota R
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The botanical drug PBI-05204, a supercritical CO
    Vaccaro S; Rossetti A; Porrazzo A; Camero S; Cassandri M; Pomella S; Tomaciello M; Macioce G; Pedini F; Barillari G; Marchese C; Rota R; Cenci G; Tombolini M; Newman RA; Yang P; Codenotti S; Fanzani A; Megiorni F; Festuccia C; Minniti G; Gravina GL; Vulcano F; Milazzo L; Marampon F
    Front Pharmacol; 2022; 13():1071176. PubMed ID: 36532747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma.
    Pomella S; Porrazzo A; Cassandri M; Camero S; Codenotti S; Milazzo L; Vulcano F; Barillari G; Cenci G; Marchese C; Fanzani A; Megiorni F; Rota R; Marampon F
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization to Ionizing Radiation by MEK Inhibition Is Dependent on SNAI2 in Fusion-Negative Rhabdomyosarcoma.
    Hensch NR; Bondra K; Wang L; Sreenivas P; Zhao XR; Modi P; Vaseva AV; Houghton PJ; Ignatius MS
    Mol Cancer Ther; 2023 Jan; 22(1):123-134. PubMed ID: 36162055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells.
    Walters ZS; Villarejo-Balcells B; Olmos D; Buist TW; Missiaglia E; Allen R; Al-Lazikani B; Garrett MD; Blagg J; Shipley J
    Oncogene; 2014 Feb; 33(9):1148-57. PubMed ID: 23435416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct Immunomodulatory Effects of Spermine Oxidase in Colitis Induced by Epithelial Injury or Infection.
    Gobert AP; Al-Greene NT; Singh K; Coburn LA; Sierra JC; Verriere TG; Luis PB; Schneider C; Asim M; Allaman MM; Barry DP; Cleveland JL; Destefano Shields CE; Casero RA; Washington MK; Piazuelo MB; Wilson KT
    Front Immunol; 2018; 9():1242. PubMed ID: 29922289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of polyamine catabolic enzymes provokes Purkinje cell damage, neuroinflammation, and severe ataxia.
    Zahedi K; Brooks M; Barone S; Rahmati N; Murray Stewart T; Dunworth M; Destefano-Shields C; Dasgupta N; Davidson S; Lindquist DM; Fuller CE; Smith RD; Cleveland JL; Casero RA; Soleimani M
    J Neuroinflammation; 2020 Oct; 17(1):301. PubMed ID: 33054763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcoma.
    Shah AM; Guo L; Morales MG; Jaichander P; Chen K; Huang H; Cano Hernandez K; Xu L; Bassel-Duby R; Olson EN; Liu N
    Sci Adv; 2023 Apr; 9(17):eade8184. PubMed ID: 37115930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.